New
Jersey
|
22-3506376
|
(State
or other jurisdiction of
incorporation
or organization)
|
(IRS
Employer Identification No.)
|
|
Page
|
|
Balance
Sheets
|
4
|
Statements
of Operations and Deficit Accumulated
|
|
During
Development Stage
|
5
|
Statements
of Cash Flows
|
6
|
Notes
to Financial Statements
|
7
|
March
31,
2005
|
December
31, 2004
|
||||||
ASSETS
|
(Unaudited)
(Restated)
|
||||||
Current Assets | |||||||
Cash
|
$
|
3,187,890
|
$
|
641,477
|
|||
Accounts
receivable
|
76,991
|
-
|
|||||
Accrued
interest receivable
|
147,447
|
86,667
|
|||||
Inventory
|
1,050,552
|
709,281
|
|||||
Prepaid
expenses
|
-
|
5,113
|
|||||
Vendor
advance
|
129,017 |
52,017
|
|||||
Deferred
tax asset
|
282,559
|
224,414
|
|||||
Total
current assets
|
$
|
4,874,456
|
$
|
1,718,969
|
|||
Fixed
Assets
|
|||||||
Office
furniture and equipment
|
96,807
|
90,714
|
|||||
Automotive
equipment
|
21,221
|
21,221
|
|||||
Shop
equipment
|
26,446
|
24,553
|
|||||
Casts
and tooling
|
205,485
|
205,485
|
|||||
349,959
|
341,973
|
||||||
Less, accumulated depreciation |
257,489
|
248,386
|
|||||
Net
fixed assets
|
92,470
|
93,587 | |||||
Other
Assets
|
|||||||
Advances
to FiLCO GmbH
|
3,825,000
|
2,670,000
|
|||||
Patents
- net
|
129,970 |
117,402
|
|||||
Utility
deposits
|
65
|
65
|
|||||
Total
other assets
|
3,955,035
|
2,787,467
|
|||||
TOTAL
ASSETS
|
$
|
8,921,961
|
$
|
4,600,023
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Current
Liabilities
|
|||||||
Accounts
payable
|
$
|
446,845
|
$
|
394,959
|
|||
Accrued
liabilities
|
463,013
|
459,565
|
|||||
Liability
for warrants and conversion options
|
2,529,429
|
1,219,750
|
|||||
Shareholder
deposits for stock
|
-
|
1,403,174
|
|||||
Shareholder
notes payable
|
34,459
|
33,455
|
|||||
Total
current liabilities
|
3,473,746
|
$
|
3,510,903
|
||||
Stockholders’
Equity
|
|||||||
Common
stock - authorized, 100,000,000 shares without
|
|||||||
par
value; 21,216,215 and 15,089,342 issued and
|
|||||||
outstanding,
respectively
|
20,707,594
|
10,822,854
|
|||||
Preferred
stock - authorized, 5,000,000 shares without
|
|||||||
par
value; 275,000 issued and outstanding
|
12,950
|
12,950
|
|||||
Deficit
accumulated during the development stage
|
(15,065,377
|
)
|
(9,539,732
|
)
|
|||
Deficit
prior to development stage
|
(206,952
|
)
|
(206,952
|
)
|
|||
Total
stockholders’ equity
|
5,448,215
|
1,089,120
|
|||||
TOTAL
LIABILITIES AND STOCKHOLDERS’
EQUITY
|
|||||||
$
|
8,921,961
|
$
|
4,600,023
|
(Restated)
2005
|
2004
|
May
19, 1997
(Date
of Inception) to March 31, (Restated)
|
||||||||
SALES
|
$
|
76,991
|
$ | - | $ | 1,100,114 | ||||
COST
OF GOODS SOLD
|
52,361
|
- | 522,732 | |||||||
Gross
Profit (Loss)
|
24,630 |
-
|
577,382
|
|||||||
OPERATING
AND ADMINISTRATIVE EXPENSES
|
723,594
|
298,809
|
9,559,960 | |||||||
OPERATING
LOSS
|
(698,964
|
)
|
(298,809
|
)
|
(8,982,578
|
)
|
||||
OTHER
INCOME AND EXPENSE
|
||||||||||
Revaluation
income (expense)
|
226,859
|
-
|
(637,421
|
)
|
||||||
Interest
expense
|
(40,272
|
)
|
(7,604 | ) | (215,336 | ) | ||||
Interest
income
|
61,144
|
-
|
147,811
|
|||||||
Other
income
|
136 |
-
|
78,430
|
|||||||
Conversion
expense
|
(5,132,693 | ) |
-
|
(5,600,018
|
)
|
|||||
NET
LOSS BEFORE INCOME TAXES
|
(5,583,790
|
)
|
(306,413
|
)
|
(15,209,112
|
)
|
||||
INCOME
TAX BENEFIT (STATE):
|
||||||||||
Current
|
58,145
|
25,959 |
58,145
|
|||||||
Prior
years
|
- |
-
|
717,142
|
|||||||
Total
Benefit
|
58,145
|
25,959
|
775,287
|
|||||||
LOSS
ACCUMULATED DURING
|
||||||||||
DEVELOPMENT
STAGE
|
(5,525,645
|
)
|
(280,454
|
)
|
(14,433,825
|
)
|
||||
DEEMED
DIVIDEND ON PREFERRED STOCK
|
-
|
-
|
188,412
|
|||||||
NET
LOSS ATTRIBUTABLE TO COMMON
|
||||||||||
SHAREHOLDERS
|
(5,525,645 | ) |
(280,454
|
)
|
(14,622,237
|
)
|
||||
PREFERRED
STOCK DIVIDENDS DURING
|
||||||||||
DEVELOPMENT
STAGE
|
-
|
(45,833
|
)
|
(443,140
|
)
|
|||||
DEFICIT
ACCUMULATED DURING DEVELOPMENT
|
||||||||||
STAGE
|
$
|
(5,525,645
|
)
|
$
|
(326,287
|
)
|
$ | (15,065,377 | ) | |
EARNINGS
PER SHARE:
|
||||||||||
NET
LOSS ATTRIBUTABLE TO COMMON
|
||||||||||
SHAREHOLDERS
|
$ | (5,525,645 | ) |
$
|
(280,454
|
)
|
||||
ADJUSTMENT
FOR PREFERRED DIVIDENDS
|
(17,188
|
)
|
(17,188 | ) | ||||||
DEFICIT
ALLOCABLE TO COMMON SHAREHOLDERS
|
$
|
(5,542,833
|
)
|
$ | (297,642 | ) | ||||
NET
LOSS PER SHARE - Basic and Diluted
|
$
|
(.36
|
)
|
$
|
(.03
|
)
|
||||
WEIGHTED
AVERAGE SHARES OUTSTANDING
|
15,523,209
|
9,336,042 |
|
|
|
2005
Restated
|
|
|
2004
|
May
19, 1997
(Date
of Inception)
to
March 31, 2005 Restated
|
|||
CASH
FLOWS FROM OPERATING ACTIVITIES
|
||||||||||
Net
Loss
|
$
|
(5,525,645
|
)
|
$
|
(280,454
|
)
|
$
|
(14,622,237
|
)
|
|
Adjustments
to reconcile net income to net cash
|
||||||||||
consumed
by operating activities:
|
||||||||||
Charges
not requiring the outlay of cash:
|
||||||||||
Depreciation
and amortization
|
10,833
|
9,053
|
312,030
|
|||||||
Value
of common stock issued for services
|
5,113
|
145,539 |
2,832,481
|
|||||||
Value
of options granted for services
|
83,650
|
-
|
83,650
|
|||||||
Revaluation
expense (income)
|
(226,859
|
)
|
-
|
637,421
|
||||||
Conversion
expense
|
5,132,693
|
-
|
5,600,018
|
|||||||
Increase
in accrual of deferred tax benefit
|
(58,145
|
)
|
(25,959
|
)
|
(282,559
|
)
|
||||
Deemed
dividends on preferred stock
|
-
|
-
|
188,412
|
|||||||
Interest
accrued on shareholder loan
|
1,004
|
1,998
|
22,645
|
|||||||
Changes
in current assets and liabilities:
|
||||||||||
Increase
in accrued interest receivable
|
(60,780
|
)
|
-
|
(147,447
|
)
|
|||||
Increase
in accounts receivable
|
(76,991
|
)
|
-
|
(76,991
|
)
|
|||||
Increase
in vendor advances
|
(77,000
|
)
|
-
|
(129,017
|
)
|
|||||
(Decrease)
Increase in accounts payable and accrued liabilities
|
(30,318
|
)
|
(269,923
|
)
|
887,866
|
|||||
Increase
in prepaid expense
|
- |
-
|
(146,957
|
)
|
||||||
Increase
in inventory
|
(341,271 | ) | (43,076 | ) |
(1,050,552
|
)
|
||||
Net
Cash Consumed By
|
||||||||||
Operating
Activities
|
(1,163,716
|
)
|
(462,822
|
)
|
(5,891,237
|
)
|
||||
CASH
FLOWS FROM INVESTING ACTIVITIES
|
||||||||||
Acquisitions
of equipment
|
(7,986
|
)
|
(2,427
|
)
|
(356,270
|
)
|
||||
Additions
to patent cost
|
(14,298
|
)
|
-
|
(170,092
|
)
|
|||||
Advances
to FiLCO GmbH
|
(1,155,000
|
)
|
(500,000
|
)
|
(3,825,000
|
)
|
||||
Net
Cash Consumed By
|
||||||||||
Investing
Activities
|
(1,177,284
|
)
|
(502,427 | () |
(4,351,362
|
)
|
||||
CASH
FLOWS FROM FINANCING ACTIVITIES
|
||||||||||
Net
proceeds of issuance of convertible debt
|
4,277,500
|
1,213,874
|
4,277,500
|
|||||||
Net
proceeds of common stock sales
|
55,000
|
-
|
8,627,611
|
|||||||
Proceeds
from option exercises
|
-
|
-
|
14,344
|
|||||||
Proceeds
from exercise of warrants
|
554,913 |
-
|
648,663
|
|||||||
Proceeds
of sales of preferred stock
|
-
|
-
|
12,950
|
|||||||
Borrowings
(repayments) of stockholder loans
|
-
|
(52,005
|
)
|
35,120
|
||||||
Preferred
stock dividends paid in cash
|
-
|
(45,833
|
)
|
(185,274
|
)
|
|||||
Principal
payments on installment note
|
- | (349 | ) |
(425
|
)
|
|||||
Net
Cash Provided By
|
||||||||||
Financing
Activities
|
4,887,413 |
1,115,687
|
13,430,489
|
|||||||
Net
Increase (Decrease) In Cash
|
2,546,413
|
150,438
|
3,187,890
|
|||||||
Balance
at beginning of period
|
641,477 | 37,388 | - | |||||||
Balance
at end of period
|
$
|
3,187,890
|
$
|
187,826
|
$
|
3,187,890
|
Class
A
|
Class
B
|
Other Warrants
|
Total Warrants
|
||||||||||
Outstanding
at December 31, 2004
|
-
|
-
|
5,537,763
|
5,537,763
|
|||||||||
Issued
in connection with conversion
|
|||||||||||||
of
convertible notes
|
1,923,077
|
961,538
|
384,616
|
3,269,231
|
|||||||||
1,923,077
|
961,538
|
5,922,379
|
8,806,994
|
||||||||||
Reductions
during the quarter:
|
|||||||||||||
Warrants
exercised
|
(462,142
|
)
|
(462,142
|
)
|
|||||||||
Warrants
voided
|
(200,000
|
)
|
(200,000
|
)
|
|||||||||
1,923,077
|
961,538
|
5,260,237 | 8,144,852 |
Conversion
of $5,000,000 notes
|
3,846,154
|
|||
Private placement sales |
68,750
|
|||
Shares issued based on warrants exercised |
462,142
|
|||
Issuance
of shares sold in prior year
|
1,749,827
|
|||
Total
shares issued
|
6,126,873
|
3. |
RESTATEMENTS
|
Statement
Of Operations
For
The Three Month Period Ended March 31, 2005
|
||||||||||
As
Originally
Presented
|
Adjustments
|
As
Restated
|
||||||||
Revaluation
income
|
$
|
-
|
$
|
226,859
(2
|
)
|
$
|
226,859
|
|||
Conversion
expense
|
-
|
(5,132,693)(1
|
)
|
(5,132,693
|
)
|
|||||
Net
loss attributable to common shareholders
|
$
|
(619,811
|
)
|
$
|
(4,905,834
|
)
|
$
|
(5,525,645
|
)
|
Statement
Of Operations
For
The Period May 19, 1997 To March 31, 2005
|
||||||||||
As
Originally
Presented
|
Adjustments
|
As
Restated
|
||||||||
Revaluation
expense
|
$
|
-
|
$
|
(637,421)(2
|
)
|
$
|
(637,421
|
)
|
||
Conversion
Expense
|
-
|
(5,600,018)(1
|
)
|
(5,600,018
|
)
|
|||||
Net
loss attributable to common shareholders
|
$
|
(8,384,798
|
)
|
$
|
(6,237,439
|
)
|
$
|
(14,622,237
|
)
|
|
||||||||||
Statement
Of Cash Flows
For
The Three Month Period Ended March 31, 2005
|
||||||||||
As
Originally
Presented
|
Adjustments
|
As
Restated
|
||||||||
Net
loss
|
$
|
(619,811
|
)
|
$
|
(4,905,834
|
)
|
$
|
(5,525,645
|
)
|
|
Revaluation
income
|
-
|
(226,859)(2
|
)
|
(226,859
|
)
|
|||||
Conversion
expense
|
-
|
5,132,693(1
|
)
|
5,132,693
|
||||||
Cash
consumed by operating activities
|
$
|
(1,163,716
|
)
|
$
|
-___
|
$
|
(1,163,716
|
)
|
Statement
Of Cash Flows
For
The Period May 19, 1997 To March 31, 2005
|
||||||||||
As
Originally
Presented
|
Adjustments
|
As
Restated
|
||||||||
Net
loss
|
$
|
(8,384,798
|
)
|
$
|
(6,237,439
|
)
|
$
|
(14,622,237
|
)
|
|
Revaluation
expense
|
-
|
637,421
(2
|
)
|
637,421
|
||||||
Conversion
expense
|
-
|
5,600,018(1
|
)
|
5,600,018
|
||||||
Cash
consumed by operating activities
|
$
|
(5,891,237
|
)
|
$
|
-___
|
$
|
(5,891,237
|
)
|
|
|||||||||||
Balance
Sheet March
31, 2005
|
|||||||||||
Liabilities
and Stockholders’ Equity
|
As
Originally
Presented
|
Adjustments
|
As
Restated
|
||||||||
Liabilities:
|
|||||||||||
Liability
for warrants and conversion options
|
$
|
-
|
$
|
2,529,429
|
)
|
(1)(2) |
$
|
2,529,429
|
|||
Total
liabilities
|
944,317
|
2,529,429
|
3,473,746
|
||||||||
Stockholders’
Equity:
|
|||||||||||
Common
stock
|
16,999,584
|
3,708,010
|
)
|
(1) |
20,707,594
|
||||||
Deficit
accumulated during development stage
|
(8,827,938
|
)
|
(5,600,018
|
)
|
(1) |
(15,065,377
|
)
|
||||
(637,421 | ) | (2) | |||||||||
Total
stockholders’ equity
|
7,977,644
|
(2,529,429
|
)
|
5,448,215
|
|||||||
Total
Liabilities and Stockholders’ Equity
|
$
|
8,921,261
|
$
|
-
|
$
|
8,921,261
|
(1) |
Conversion
expense associated with stock conversion and immediately exercisable
warrants, not previously recorded.
|
3
Months Ended 3/31/05
|
3
Months Ended
3/31/04
|
||||||
Officer’s
Compensation
|
$
|
83,650
|
$
|
-
|
|||
Salaries
|
121,594
|
67,270
|
|||||
Marketing
Expense
|
133,012
|
7,459
|
|||||
Production
Costs
|
100,903
|
16,350
|
|||||
Professional
Fees
|
118,364
|
32,607
|
|||||
Consulting-Administrative
|
5,113
|
51,250
|
|||||
Consulting-Marketing
|
-
|
75,000
|
|||||
Other
Expenses
|
160,958 | 48,873 | |||||
Totals
|
$
|
723,594
|
$
|
298,809
|
AIRTRAX,
INC.
|
||
|
|
|
Date: May 15, 2007 | By: | /s/ ROBERT WATSON |
Robert
Watson
|
||
President,
Chief Executive Officer (Principal Executive Officer) and Acting
Chief
Financial Officer (Principal Financial Officer and Principal Accounting
Officer)
|